Mumbai: Mumbai-based Inventys Research Company has raised Rs 225 crore through private placement from Plutus Wealth Management and Pantomath Capital Management.
Plutus Wealth Management committed Rs 225 crores of primary infusion into the company. At the same time, India Inflection Opportunity Fund, managed by Pantomath Capital Management, picks up the secondary round offered by certain existing shareholders of the company.
Inventys is a research-driven specialty chemical manufacturer focusing on custom synthesis and manufacturing (CSM). The company has a diversified product portfolio comprising Advanced Intermediates & Actives used in Crop-Protection and Pharmaceutical applications and other specialty segments.
Pantomath Capital Advisors Private Limited acted as the sole investment banker for the transaction.
Discover the stories of your interest
Stay on top of technology and startup news that matters. Subscribe to our daily newsletter for the latest and must-read tech news, delivered straight to your inbox.
